ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 352299 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 352299; 2) Community: the network communities that were significantly associated with the response to NSC 352299; 3) Molecule: the relationships between components within communities and NSC 352299; 4) MDR: the compounds that were significantly associated with the NSC 352299.

NSC Compound Enrichment Correlation
NSC 762149 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)acetamide 0.0382675857669585 0.059039235
NSC 77810 Naphtho[1,2-b]quinolizinium, 9-methyl-, bromide 0.0382675857669585 0.649928
NSC 93739 Aizen Magenta 0.0382675857669585 0.60457029
NSC 10848 Null 0.0382675857669588 0.17628022
NSC 111533 Methoxycamptothecin 0.0382675857669588 0.35460977
NSC 111702 p-Dioxane-2-methanol, 3,5-dihydroxy-6-[6-(methylthio)-9H-purin-9-yl]- 0.0382675857669588 -0.25222277
NSC 116878 Cardiac glycoside 0.0382675857669588 0.024065905
NSC 129943 (+-)-(3,5,3',5'-Tetraoxo)-1,2-dipiperazinopropane 0.0382675857669588 0.20950631
NSC 245398 Null 0.0382675857669588 0.19693238
NSC 26273 6-Benzylthioinosine 0.0382675857669588 -0.16902033
Total:53  Current:41    [First] [Prev] [Next] [Last]